Mannkind (MNKD) Construction in Progress (2021 - 2022)

Mannkind's (MNKD) quarterly Construction in Progress came in at $7.7 million in Q1 2022, up 63.83% on a QoQ basis from $4.7 million in Q4 2021.

Mannkind (MNKD) Construction in Progress (2021 - 2022) Analysis & Trends

Mannkind (MNKD) has 2 years of Construction in Progress data on file, last reported at $7.7 million in Q1 2022.

On a quarterly basis, Construction in Progress changed N/A year-over-year to $7.7 million in Q1 2022; TTM through Mar 2022 was $7.7 million, a N/A change from a year earlier, with the FY2021 full-year figure at $4.7 million, changed N/A from the prior year.
Construction in Progress for Q1 2022 stood at $7.7 million, up from $4.7 million in the prior quarter.
Over the last five years, Construction in Progress for MNKD reached as high as $7.7 million in Q1 2022 and fell as low as $1.6 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Construction in Progress (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	137.45 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Mannkind	1.20 Bn	1.07 Bn	82.66 Mn	-

Download Data